245 related articles for article (PubMed ID: 16631966)
21. [Dyscromic neurocutaneous syndromes].
Sola-Casas MA; Salleras-Redonnet M
Rev Neurol; 1997 Sep; 25 Suppl 3():S259-64. PubMed ID: 9273171
[TBL] [Abstract][Full Text] [Related]
22. Retinoid therapy of pigmentary disorders.
Ortonne JP
Dermatol Ther; 2006; 19(5):280-8. PubMed ID: 17014483
[TBL] [Abstract][Full Text] [Related]
23. [Hereditary pigmentary disorders].
Giehl K; Braun-Falco M
Hautarzt; 2010 Jul; 61(7):567-77. PubMed ID: 20556350
[TBL] [Abstract][Full Text] [Related]
24. Common pigmentation disorders.
Plensdorf S; Martinez J
Am Fam Physician; 2009 Jan; 79(2):109-16. PubMed ID: 19178061
[TBL] [Abstract][Full Text] [Related]
25. Reticulate hyperpigmented scleroderma: a new pigmentary manifestation.
Ee HL; Tan SH
Clin Exp Dermatol; 2005 Mar; 30(2):131-3. PubMed ID: 15725237
[TBL] [Abstract][Full Text] [Related]
26. Melasma in Latina patients: cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language.
Dominguez AR; Balkrishnan R; Ellzey AR; Pandya AG
J Am Acad Dermatol; 2006 Jul; 55(1):59-66. PubMed ID: 16781293
[TBL] [Abstract][Full Text] [Related]
27. Linear and whorled hypermelanosis.
Di Lernia V
Pediatr Dermatol; 2007; 24(3):205-10. PubMed ID: 17542865
[TBL] [Abstract][Full Text] [Related]
28. Generalized mottled pigmentation with postnatal skin blistering in three generations.
Westerhof W; Dingemans KP
J Am Acad Dermatol; 2004 May; 50(5 Suppl):S65-9. PubMed ID: 15097931
[TBL] [Abstract][Full Text] [Related]
29. Insights into melanosomes and melanin from some interesting spatial and temporal properties.
Simon JD; Hong L; Peles DN
J Phys Chem B; 2008 Oct; 112(42):13201-17. PubMed ID: 18817437
[TBL] [Abstract][Full Text] [Related]
30. Genetic disorders of pigmentation.
Passeron T; Mantoux F; Ortonne JP
Clin Dermatol; 2005; 23(1):56-67. PubMed ID: 15708290
[TBL] [Abstract][Full Text] [Related]
31. An animal model for the study of azidothymidine-induced hyperpigmentation.
Roth RI; Baker G; Levin J
Lab Invest; 1991 Mar; 64(3):437-9. PubMed ID: 2002660
[TBL] [Abstract][Full Text] [Related]
32. A review of genetic disorders of hypopigmentation: lessons learned from the biology of melanocytes.
Dessinioti C; Stratigos AJ; Rigopoulos D; Katsambas AD
Exp Dermatol; 2009 Sep; 18(9):741-9. PubMed ID: 19555431
[TBL] [Abstract][Full Text] [Related]
33. Laser induced chrysiasis: disfiguring hyperpigmentation following Q-switched laser therapy in a woman previously treated with gold.
Almoallim H; Klinkhoff AV; Arthur AB; Rivers JK; Chalmers A
J Rheumatol; 2006 Mar; 33(3):620-1. PubMed ID: 16511932
[No Abstract] [Full Text] [Related]
34. Pollution as a risk factor for the development of melasma and other skin disorders of facial hyperpigmentation ‑ is there a case to be made?
Roberts WE
J Drugs Dermatol; 2015 Apr; 14(4):337-41. PubMed ID: 25844605
[TBL] [Abstract][Full Text] [Related]
35. Validation of a melasma quality of life questionnaire for the Turkish language: the MelasQoL-TR study.
Dogramaci AC; Havlucu DY; Inandi T; Balkrishnan R
J Dermatolog Treat; 2009; 20(2):95-9. PubMed ID: 18720186
[TBL] [Abstract][Full Text] [Related]
36. Effect of melasma on quality of life in a sample of women living in southern Brazil.
Freitag FM; Cestari TF; Leopoldo LR; Paludo P; Boza JC
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):655-62. PubMed ID: 18410339
[TBL] [Abstract][Full Text] [Related]
37. Familial progressive hyperpigmentation.
Chernosky ME; Anderson DE; Chang JP; Shaw MW; Romsdahl MM
Arch Dermatol; 1971 Jun; 103(6):581-91 passim. PubMed ID: 4326548
[No Abstract] [Full Text] [Related]
38. X-linked reticulate pigmentary disorder with systemic manifestations: report of a third family and literature review.
Anderson RC; Zinn AR; Kim J; Carder KR
Pediatr Dermatol; 2005; 22(2):122-6. PubMed ID: 15804299
[TBL] [Abstract][Full Text] [Related]
39. Melanocyte-stimulating-hormone levels in doxorubicin-induced hyperpigmentation.
Kew MC; Mzamane D; Smith AG; Shuster S
Lancet; 1977 Apr; 1(8015):811. PubMed ID: 66615
[No Abstract] [Full Text] [Related]
40. [Molecular basis of pigmentation disorders in skin diseases].
Drukała J; Bobis S; Zabińska-Płazak E; Wojas-Pelc A
Przegl Lek; 2009; 66(3):145-9. PubMed ID: 19689040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
